Interestingly, silencing of the facilitative glucose transporter GLUT1 in MDA-MB-231 or Hs578T breast cancer cells resulted in decreased expression of β1 integrin, reduced Src and FAK phosphorylation, and decreased cell growth and migration [209]. This evidence concerns the gene PTK2 and breast cancer.